Olanzapine IR Pellets Manufacturer in India

Olanzapine IR Pellets Manufacturer in India

Pharmaceutical-Grade Olanzapine IR Pellets for Immediate-Release Oral Formulations

Olanzapine IR Pellets are multiparticulate pharmaceutical formulations designed for immediate-release oral dosage applications. Olanzapine is identified by CAS Number 132539-06-1, molecular formula C₁₇H₂₀N₄S, and molecular weight 312.40 g/mol. These chemical identifiers are confirmed by PubChem.

The SDP pellet product portfolio lists Olanzapine IR Pellets at 2.50% strength, providing a defined active-loading option for pharmaceutical formulation development.

The immediate-release pellet format provides a multiparticulate platform designed for release of the active ingredient according to the applicable formulation specification. Pellet composition, active loading, particle characteristics and manufacturing parameters influence the final release performance.

Key Features

• Olanzapine immediate-release pharmaceutical pellets
• 2.50% active ingredient strength
• Pharmaceutical-grade multiparticulate formulation
• Immediate-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Defined active ingredient loading
• Product-specific quality parameters
• Formulation flexibility
• Suitable for bulk pharmaceutical requirements

Product Information

Olanzapine has the molecular formula C₁₇H₂₀N₄S and molecular weight 312.40 g/mol. PubChem identifies 132539-06-1 as the CAS Number for Olanzapine.

For Olanzapine IR Pellets, the 2.50% value represents active ingredient loading in the finished pellet formulation. It should not be confused with the purity assay of the Olanzapine raw material.

Available Strength

Olanzapine IR Pellets — 2.50%

The 2.50% strength is listed for Olanzapine IR Pellets in the referenced pharmaceutical pellet product portfolio.

Applications

Olanzapine IR Pellets can be considered for:

• Immediate-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Olanzapine IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 2.50% Strength: Defined active-loading option for formulation development.
• Immediate-Release Format: Designed for immediate-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
• Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
• Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Olanzapine IR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp